October 9th, 2015

Prostate Cancer: Living, Not Just Surviving

By Jane Griffiths, Company Group Chairman, Janssen EMEA and Executive Sponsor, Janssen Sustainability Council

Janssen report focuses on quality of life for prostate cancer survivors

Prostate Cancer: Living, Not Just SurvivingMore than three million men in Europe have prostate cancer and almost half of them have lived with the disease for five years or more, according to European Commission. Advances in the management of prostate cancer means that more patients are beating the disease and looking ahead at what it means to live as a survivor.

To bring focus to the issues facing prostate cancer survivors, the team at Janssen recently launched the Prostate Cancer: Living, not Just Surviving report, summarizing findings of a pan-European survey of prostate cancer patients, caregivers and healthcare professionals looking at the physical, emotional and social impact of prostate cancer. Some key findings in the report include:[i]

  • Fatigue (66%) has the biggest negative impact on patients reporting chronic physical effects from the disease, over disability and pain (41% and 22% respectively)
  • Prostate cancer patients are more likely to worry about intimacy problems (54%) than dying (36%), however nearly two-thirds (62%) of patients are not willing to talk about such intimacy problems with their partner
  • In prostate cancer patients:
    • 80% are unable to do activities they used to enjoy before diagnosis
    • 85% are unable to be intimate with their partner following diagnosis
  • Only 14 percent of healthcare professionals feel that they have sufficient resources to address these types of quality of life issues

This launch is the culmination of more than two years’ work, involving many patient organisations from across Europe.

Read More

October 9th, 2015

From Couch Potato to IRONMAN: How I Did it – With Type 1 Diabetes

By Casey Boren

Casey Boren by the ocean pre-race

My First Tri

When I was growing up, my parents owned a running store, and I swore I’d never be a runner. Call it rebellion.

Instead, I grew up, got married and was running computer systems for Starbucks. Then, in September of 2003, when I was 33, my wife’s brother and sister and some friends came out to Seattle to do a fun little mini-triathlon. They weren’t extreme athletes by a longshot: This was just a half-mile swim, a 15-mile bike ride, and a 5K run, which is about 3.2 miles.

Of course, at that point in life, my favorite activity was pretty much watching ESPN. But these guys were so enthusiastic about this race, and they kept encouraging me to do it with them. I actually don’t quite know how it all happened. They were like “Come on, man, you can do it!” And I was like, “I haven’t trained!” A few hours (and a few beers) later, they had me convinced.

When I say I was unprepared, I’m not kidding: I didn’t even own a bike. Well, strike that: I had a cute, little hipster-cruiser bike. I didn’t have running shoes – just cross-trainers. I had no idea what I was getting into.

Read More

October 9th, 2015

Preventing the Next Ebola Outbreak

By Paul Stoffels, M.D., Chief Scientific Officer and Worldwide Chairman, Pharmaceuticals, Johnson & Johnson

Vaccine Volunteer Idrissa Kamara

Early this January, just six weeks after Johnson & Johnson announced the acceleration of an Ebola vaccine program in response to the world’s deadliest Ebola outbreak, a team of us flew to Sierra Leone to begin exploring the possibility of conducting a clinical trial there.

That same week, Sierra Leone had recorded almost 250 cases of Ebola, and since March 2014, almost 10,000 cases and nearly 3,000 deaths. The devastation we saw on that first trip was horrifying.

Today, Ebola no longer terrorizes the people of Liberia, Guinea and Sierra Leone, other African countries or the rest of the world. And just this week, since March 2014, the World Health Organization reported no new cases.

This is the result of dedicated work and collaboration by health care workers, non-profit organizations, civil societies and foundations, local and foreign governments and the private sector who are now focused on the hard work of recovery and on the lessons learned for preparedness.

The threat of Ebola has abated for the moment, but we have another threat we must watch out for – complacency.

Without a treatment, licensed vaccine, or cure for Ebola, we risk once again a lack of preparedness for the next time an Ebola outbreak happens.

Read More

October 8th, 2015

An Asia Pacific Roadmap for Partnership in Mental Health

By Ai Hua Ong, President, One Johnson & Johnson South East Asia


I recently had the opportunity to attend the fifth annual Asia Pacific Economic Cooperation (APEC) High Level Meeting on Health & the Economy in Cebu, Philippines where I joined a panel discussion on mobilizing a cross-sectoral approach to improving health awareness and services delivery that involves government, business and non-government organizations.

Over the last two decades, we have seen an exponential growth in the number of multi-sectoral collaborations and public-private partnerships tackling some of the world’s deadliest infectious diseases, such as HIV, Ebola and Tuberculosis. It was clear from the panel discussion that multi-sectoral approaches are expanding to areas of healthcare previously thought of as sector-siloed, including health awareness, service delivery and system strengthening. Today multi-sectoral approaches have the potential to reconfigure the landscape, driving innovation wherever health-creation opportunities exist, and there is a need for more such cooperation in the Asia-Pacific region.

One area in need of urgent attention is mental illness, which imposes a substantial burden on individuals and their loved ones, as well as employers, governments and society as a whole. The economic burden of mental illness is significant and research has shown that these diseases have a high impact on economies through losses in productivity and total care costs.

Read More

October 5th, 2015

Policies that Underestimate NCDs Could Blunt Economic Growth in Asia

By Kris Sterkens, Company Group Chairman, Janssen, the pharmaceutical companies of Johnson & Johnson, Asia Pacific

A new report from the EcoShifting Landscape of HC in AP_Page_1nomist – The Shifting Landscape of Healthcare in Asia Pacific confirms that people in our region are living longer, but not necessarily healthier, with overburdened, provider-led healthcare systems that lack comprehensive strategies to address emerging non-communicable diseases (NCDs) such as cancer, diabetes and mental illness.

We provided a grant for the development of this independent research report, which examines whether current health policies in Australia, China, India, Japan and South Korea are coping with the sharp rise of NCDs while these countries continue to tackle an existing burden of infectious diseases, such as tuberculosis and hepatitis.

There is a quote in the report by Professor Aikichi Iwamoto, chair of Japan’s National HIV Surveillance Committee, who notes that one difficulty in dealing with the HIV/AIDS epidemic in much of Asia is that “health systems in many countries are more adjusted to acute infections where people are cured by antimicrobials in five days.”

This accurately captures the history of a region that has endured deadly emergency outbreaks of viruses and influenzas for more than a century, most recently with SARS and Avian Flu.

Read More

October 2nd, 2015

Meaningful Innovation for Better Patient Outcomes

By Gary Pruden, Worldwide Chairman, Johnson & Johnson Medical Devices

AdvaMed - Gary Pruden

At Johnson & Johnson, we have a strong partnering model that has set us apart in harnessing innovation, wherever it resides. In our Medical Devices Group, that tradition has led to advances of novel products and technologies in key areas like general and specialized surgery, orthopaedics, cardiovascular disease, neurosurgery, and infection prevention. For us, innovation means identifying meaningful insights and building on those insights to deliver better patient outcomes, particularly in key medical areas like cancer, obesity and trauma.

AdvaMed 2015 Med Tech conference

That’s why this week’s AdvaMed 2015 Med Tech conference is such an important opportunity for us to share our vision as a global leader in medical devices and a valued partner too. Through our trusted brands like Ethicon, DePuy Synthes, Biosense Webster and others, we are delivering products and solutions across the total care continuum to increase patient satisfaction, improve clinical outcomes and reduce costs. In the United States and globally, one way we are doing this is by streamlining our service models and combining our portfolio offerings to deliver total solutions across entire specialty procedures, such as Thoracic, Bariatric and Joints. We are also working with many U.S.

Read More

September 30th, 2015

Cultivating Talent Diversity at Johnson & Johnson

By Joaquin Duato, Worldwide Chairman, Pharmaceutical, Johnson & Johnson

King Felipe VI and Queen Letizia of Spain

King Felipe VI and Queen Letizia of Spain

Recently I had the honor of meeting King Felipe VI and Queen Letizia of Spain, during their visit to St. Augustine, Florida for the 20th U.S. Spain Council Forum. This was an especially proud moment for me. Even though earlier this year I had the honor of being sworn in as a U.S. citizen, my roots are still in my birth place of Spain.

It is remarkable to think that the son of a nurse and an engineer from Valencia, Spain would one day be part of the U.S. delegation meeting with the Spanish Royal family. Even more remarkable is the fact that my story is not unique. Many employees across Johnson & Johnson no longer work in their home geographies and instead have relocated to other regions and countries to gain invaluable insights about the global village we are all a part of today. Johnson & Johnson understands the business value gained by employing an international workforce with diverse backgrounds and cultural experiences who can all work together towards achieving healthcare milestones for patients and consumers around the world.

Promoting International Talent Diversity

I have worked in three countries, two regions and at a global level during my 26 year tenure at Johnson & Johnson.  I firmly believe that at every level of our company we should have a broad representation of experiences and perspectives.  The Pharmaceuticals management team I co-lead has people from 6 nationalities who have worked across dozens of markets.  We also benefit from strong gender diversity, with 8 men and 7 women making up this team.

Read More

September 28th, 2015

Janssen Teams Up With Sports Stars For AFib Awareness

Editor’s note: Atrial fibrillation, or AFib, is a type of irregular heart beat. It can sometimes be felt as a fluttering or “thumping” in the chest. Since the heart isn’t pumping properly, blood may pool in the upper chambers and form a clot. This clot can break free, travel to the brain, and cause a stroke.

In honor of AFib Awareness Month, 39-Time Grand Slam Tennis Champion Billie Jean King and 14-Time Basketball All-Star Jerry West are working with Janssen Pharmaceuticals, Inc., a Johnson & Johnson company, to help raise awareness about this health condition. Below, they share their stories. Plus, read on for a simple tool to help you evaluate your risk.

Jerry’s Story

When I hit the court as a Los Angeles Laker, I loved the feeling of making a game-winning play and knowing I was on top of my game. But when I had to start breathing into a paper bag during games to keep from hyperventilating and my heart felt out-of-rhythm, I knew something was wrong. It wasn’t until after I stopped playing professional basketball that I was diagnosed with atrial fibrillation (AFib), an irregular heartbeat and one of the most common serious heart rhythm disorders in people over the age of 65.

Read More

September 25th, 2015

Know Your Value: How J&J’s Janis Smith-Gomez Went from ‘Human Doing’ to ‘Human Being’

As part of the Johnson & Johnson-sponsored Know Your Value tour, a nationwide effort focused on empowering all of us to express our worth in business and in life hosted by MSNBC’s Mika Brzezinski, our colleague Janis Smith-Gomez will take the stage in Chicago today to talk about how she came to know her value and what it means in her life. She shared some thoughts with us about how an unexpected family crisis changed her outlook, her priorities and the way she manages her energy.  


Janis Smith-Gomez with her daughter Anna, and her husband Todd

JNJBlog: Tell us a little bit about your career and where you are today.

Janis:  I started my career at Johnson & Johnson 9 years ago and I’ve had the opportunity to hold multiple positions within the company – first focusing on nutritionals and skincare in our Consumer business, and now leading the U.S. marketing team at Ethicon. Today, I’m fortunate to see the amazing work of doctors firsthand and see how, with the help of our products, they are able to improve and save patients’ lives.

JNJBlog:  You had the chance to participate in “corporate athlete” training with our Johnson & Johnson Human Performance Institute (HPI) in 2010.

Read More

September 23rd, 2015

J&J Employee Chosen to Sing in Papal Choir during Pope Francis’ Visit

Published by the J&J Content Lab

Papal Choir

(From left to right) Papal Choir members Dr. John Shaddy, Susie Shaddy, Emma Rhine, David Maliakel

Susie Shaddy’s life has been one marked by a series of callings: to honor her Catholic faith, help patients as an operating room nurse and Johnson & Johnson employee, and sing for Pope Francis during his first visit to United States.

That last goal seemed the hardest to fulfill. That is, until Susie read in June that Pope Francis would be visiting Philadelphia this month.

“This week is my anniversary, so I said to my husband: You know what? It would be fun if we got in the choir for the Pope as something to do for our anniversary. Some couples play tennis, some play golf. We sing.”

After a rigorous tryout process that rivaled a reality show audition, Susie, her husband and two other church members got the news that they ‘d been selected to be part of a 250-person choir that will perform for Pope Francis this Sunday with the Philadelphia orchestra at the Ben Franklin Parkway.

When not making command performances like these, Shaddy and her husband John are active parishioners at Saint Gregory the Great in Hamilton, NJ, where Susie is a cantor and John is the director of the church choir.

Read More